Vystar Corp (VYST)

[broheim]

RXAir spinoff is estimated in this environment to have a value between 20 and 30 million and perhaps considerably more. We need to await word on the venture/seed capital offered to glean a more approximate valuation. The idea is with this seed capital and subsequent spinoff RXAir can garner greater investor awareness separated from the other businesses. Assume the furniture and laytex businesses are worth approx one cent, then RXAir should be worth at least between 2 and 3 cents getting the share price to .04 or a 400% increase from current levels and within weeks. I understand that there have been past frustrations but the purchase of Flu Tech was a fortuitous purchase. An independent study similarly done with SARS and done with SARS2 could make RXAir a necessary component for every business worldwide- imagine Protected by RXAir. Read the independent studies undertaken in re MERS and SARS. The co may have been a joke but with the right PR and mgmt this stock could go up 15 fold (.15 cents) in a month. The risk/reward here is ridiculous